$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
达克替尼治疗肺癌疗效怎样呢?
2025-10-19 11:44:20
Check Details
达克替尼治疗效果怎样?
2025-10-19 11:44:20
Check Details
怎么使用达克替尼?
2025-10-19 11:44:20
Check Details
达可替尼治疗肺癌疗效如何?
2025-10-19 11:44:20
Check Details
达可替尼适合什么人用?
2025-10-19 11:44:20
Check Details
EGFR T790M阳性非小细胞肺癌:阿法替尼序贯奥希替尼治疗带来近4年的总生存期
2025-10-19 11:44:20
Check Details
纳武单抗是一种什么样的药物呢?
2025-10-19 11:44:20
Check Details
纳武单抗进医保没?
2025-10-19 11:44:20
Check Details
纳武单抗治疗非小细胞肺癌疗效如何?
2025-10-19 11:44:20
Check Details
拉罗替尼治疗肺癌的效果怎样?
2025-10-19 11:44:20
Check Details
拉罗替尼怎么使用?
2025-10-19 11:44:20
Check Details
纳武单抗什么人才能用?
2025-10-19 11:44:20
Check Details
1
2
...
9576
9577
9578
9579
9580
9581
9582
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
2
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
3
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
4
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
5
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
6
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
7
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
8
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
9
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
10
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
11
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
12
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer